Get the Stockscreener App
1.90
24.90%
-0.63
After Hours:
1.85
-0.05
-2.63%
Co Diagnostics Inc stock is traded at $1.90, with a volume of 1.49M.
It is down -24.90% in the last 24 hours and up +38.69% over the past month.
Co-Diagnostics Inc is a molecular diagnostics company. The company develops, manufactures, licenses, and commercializes reagents used for diagnostic tests that function via the detection and/or analysis of nucleic acid molecules (DNA or RNA), including molecular tools for detection of infectious diseases. CDI's low-cost system uses its tests to diagnose tuberculosis, Zika, hepatitis B and C, Malaria, dengue and others. The Company also uses its proprietary technology to design specific tests for its Co-Dx PCR platform and to locate genetic markers for use in applications other than infectious diseases.
See More
Previous Close:
$2.53
Open:
$2.55
24h Volume:
1.49M
Relative Volume:
1.17
Market Cap:
$6.84M
Revenue:
$418.20K
Net Income/Loss:
$-46.90M
P/E Ratio:
-0.0785
EPS:
-24.1892
Net Cash Flow:
$-29.84M
1W Performance:
+21.02%
1M Performance:
+38.69%
6M Performance:
-64.22%
1Y Performance:
-87.42%
1-Day Range:
$1.8201
$2.65
1-Week Range:
$1.54
$2.77
52-Week Range:
$1.35
$3.95
Co Diagnostics Inc Stock (CODX) Company Profile
Name
Co Diagnostics Inc
Sector
Industry
Phone
(801) 438-1036
Address
2401 S FOOTHILL DRIVE, SALT LAKE CITY
Compare CODX vs ABT, SYK, MDT, BSX, EW
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|---|
CODX
Co Diagnostics Inc
|
1.90 | 9.11M | 418.20K | -46.90M | -29.84M | -24.19 |
ABT
Abbott Laboratories
|
82.56 | 146.87B | 45.13B | 6.28B | 7.38B | 3.5895 |
SYK
Stryker Corp
|
282.58 | 109.33B | 25.27B | 3.34B | 4.57B | 8.6358 |
MDT
Medtronic Plc
|
74.54 | 97.77B | 35.48B | 4.64B | 5.41B | 3.582 |
BSX
Boston Scientific Corp
|
53.37 | 80.16B | 20.62B | 3.56B | 3.48B | 2.3847 |
EW
Edwards Lifesciences Corp
|
77.17 | 46.04B | 6.30B | 1.07B | 1.09B | 1.8406 |
Co Diagnostics Inc Stock (CODX) Upgrades & Downgrades
| Date | Action | Analyst | Rating Change |
|---|---|---|---|
| Aug-12-22 | Downgrade | Sidoti | Buy → Neutral |
| Dec-29-21 | Initiated | Sidoti | Buy |
| Mar-29-21 | Downgrade | Maxim Group | Buy → Hold |
| May-20-20 | Upgrade | Maxim Group | Hold → Buy |
| May-18-20 | Reiterated | H.C. Wainwright | Buy |
| Mar-09-20 | Reiterated | H.C. Wainwright | Buy |
| Mar-03-20 | Downgrade | Maxim Group | Buy → Hold |
View All
Co Diagnostics Inc Stock (CODX) Latest News
Exclusive: Co-Diagnostics ships diagnostic tests to India ahead of TB study launch - MSN
Earnings Preview: CODX to Report Financial Results Post-market on May 14 - Moomoo
Co-Diagnostics JV secures KSA facility lease deal; CODX rallies 16% premarket - MSN
Co-Diagnostics (CODX) Secures Lease for Manufacturing Facility i - GuruFocus
A 14,400-square-foot diagnostics plant moves ahead in Saudi Arabia - Stock Titan
Co-Diagnostics joint venture finalizes Saudi facility lease By Investing.com - Investing.com Australia
Co-Diagnostics joint venture finalizes Saudi facility lease - Investing.com
CODX Stock Pops As Co-Diagnostics Showcases Co-Dx PCR In Europe - timothysykes.com
Co-Diagnostics Joint Venture CoMira Finalizes Lease Agreement for Manufacturing Facility in Saudi Arabia's Sudair Industrial City - 富途牛牛
CODX Technical Analysis | Trend, Signals & Chart Patterns | CO-DIAGNOSTICS INC (NASDAQ:CODX) - ChartMill
Co-Diagnostics Announces First Quarter 2026 Earnings Release Date and Webcast - BioSpace
CODX stock plunges to all-time lows on 1-for-30 reverse stock split approval - MSN
Co-Diagnostics Q3 2025 Earnings Preview - MSN
Co-Diagnostics Q2 2025 Earnings Preview - MSN
CoDiagnostics (CODX) Upgraded to Buy: Here's What You Should Know - MSN
Co-Diagnostics Reports Full Year 2025 Financial Results (PR Newswire) - Aktiellt
CODX Financials: Income Statement, Balance Sheet & Cash Flow | Co-Diagnostics Inc - Stock Titan
Co-Diagnostics (CODX) price target decreased by 37.50% to 1.28 - MSN
Co-Diagnostics (CODX) price target decreased by 20.00% to 30.60 - MSN
symbol__ Stock Quote Price and Forecast - CNN
Co-Diagnostics Invited to Present at Stop TB Partnership Summit in Washington, D.C. - BioSpace
Co-Diag (CODX) Stock Resistance Rejection (Bullish Sentiment) 2026-04-15Blue Chip Stocks - Xã Vĩnh Công
Co-Diagnostics to Showcase Co-Dx PCR Platform and CE-IVD Solutions at ESCMID 2026 in Munich, Germany - PR Newswire
CODX | Co-Diagnostics, Inc. Common Stock Insider Trading - Quiver Quantitative
Investment Review: What analysts say about Co Diagnostics Inc stockProfit Target & Daily Volume Surge Trade Alerts - baoquankhu1.vn
Will Co-Diag (CODX) Stock Recover Soon | Price at $1.39, Down 3.47%Blue Chip Stocks - Cổng thông tin điện tử Tỉnh Sơn La
Co-Diagnostics Executives to Participate in European Trade Mission with Utah Governor and WTC Utah - BioSpace
Co-Diagnostics Executives to Participate in European Trade Missi - GuruFocus
Portfolio Update: Is Co Diagnostics Inc benefiting from interest rate changesMarket Movement Recap & Low Risk High Reward Ideas - baoquankhu1.vn
Utah trade mission puts Co-Diagnostics in meetings with Roche, UBS - Stock Titan
Aug Drivers: Can Co Diagnostics Inc scale operations efficientlyWatch List & Advanced Swing Trade Entry Alerts - baoquankhu1.vn
Bull Bear: What analysts say about Co Diagnostics Inc stockTrade Risk Assessment & Real-Time Stock Entry Alerts - baoquankhu1.vn
COVID-19 Detection Kits Market Set to Boom Rapidly by 2033 | - openPR.com
Co-Diagnostics Q4 2025 earnings preview - MSN
Co-Diagnostics Earnings Call: Pipeline Progress, Cash Strain - TipRanks
Co-Diagnostics, Inc. (CODX) stock price, news, quote and history - uk.finance.yahoo.com
Q4 2025 Co-Diagnostics Inc Earnings Call Transcript - GuruFocus
Co Diagnostics Inc Stock (CODX) Financials Data
Revenue
Net Income
Cash Flow
EPS
3.34%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):